The IPV 1 is a safe and effective airway clearance device that builds on the Percussionaire legacy of IPV therapy with a Unified Connector that supports patient safety, a patient-friendly interface, and the unique efficacy of the Phasitron.

This whitepaper discusses three pediatric patient populations that are difficult to manage on mechanical ventilation and how continuous monitoring of CO2 can serve as a powerful tool to support noninvasive ventilation (NIV) strategies and therapies in the PICU.

Along with IPV therapy’s clinical results in treating patients with respiratory complications, it has a demonstrated history of being safe and well-tolerated across diverse patient populations, care settings, and delivery interfaces.

There is a long list of decisions to make when adopting new technology in a hospital unit, and transcutaneous monitoring is no exception. Some of the most overlooked decisions in our experience are those around mounting and storing the devices both during monitoring, while not in use, as well as for performing maintenance.